ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACHV

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/02/11	22:30	GlobeNewswire Inc.	Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/02/11	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/02/10	22:30	GlobeNewswire Inc.	Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/31	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/31	06:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/31	06:50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/15	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/15	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/15	06:43	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/15	06:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/15	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/15	06:38	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/15	06:37	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/11	06:05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/10	23:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/10	22:30	GlobeNewswire Inc.	Achieve Life Sciences Appoints Dr. Kristen Slaoui and Nancy Phelan to its Board of Directors	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/07	22:30	GlobeNewswire Inc.	Achieve Life Sciences Announces Critical Milestone Successfully Reached in ORCA-OL Cytisinicline Clinical Trial Required for NDA Submission	NASDAQ:ACHV	Achieve Life Sciences Inc
2025/01/06	22:30	GlobeNewswire Inc.	Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/12/10	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/12/10	06:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/12/10	06:37	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/12/10	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/12/09	22:30	GlobeNewswire Inc.	Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/12/06	06:22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/12/03	22:30	GlobeNewswire Inc.	Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/11/19	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/11/14	22:30	GlobeNewswire Inc.	Achieve Life Sciences Announces Participation at Upcoming Investor Conferences	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/11/08	06:39	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/11/08	06:25	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:ACHV	Achieve Life Sciences Inc
2024/11/08	06:15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACHV	Achieve Life Sciences Inc